NIH Clinical Pharmacology Training Program

MICROCONSTANTS CHINA PARTICIPATES IN THE NIH CLINICAL PHARMACOLOGY TRAINING PROGRAM

BEIJING, CHINA, November 20, 2009 - MicroConstants China Inc., a Contract Research Organization (CRO) specializing in bioanalysis and pharmacokinetics, announces their participation in the National Institute of Health’s (NIH) Principles of Clinical Pharmacology training program in Beijing, China. Dr. Q. David Yang, president of MicroConstants China, was a panelist at the event, and several MicroConstants employees assisted NIH experts by providing translation services during the training program.

On November 16 - 20, 2009 NIH and GlobalMD, together with the Chinese Association of Clinical Pharmacology, organized the Principles of Clinical Pharmacology training program in Beijing. The program was designed to educate clinical pharmacologists in China on recent advancements in the field, and the FDA review process of clinical pharmacology studies for new drug development.

On the final day of the training program, Dr. Q. David Yang participated on a panel covering a variety of topics such as regulatory policies, clinical pharmacology and drug development strategy for Chinese biotech companies. Other panelists included Dr. Yi Feng, director of office of evaluation management and communications at the Center for Drug Evaluation, China State FDA; Dr. Liu Ze-Yuan, director of clinical pharmacology at the 307 Hospital of People’s Liberation Army; and Dr. Mao Yi-Min, director of clinical pharmacology at Renji Hospital in Shanghai.

MicroConstants China also participated in the event by assisting with the translation of presentation materials, and serving as translators during the training program for advanced topics such as population pharmacokinetics and pharmacometrics. Four of MicroConstants’ employees provided translation services during the event ensuring that trainees were able to gain full understanding of all program topics.

Approximately 100 clinical pharmacologists including clinical researchers from government hospitals, faculty members from medical universities, and clinical research professionals from domestic and international pharmaceutical companies in China attended the four-day training program.

About MicroConstants China Inc.
MicroConstants China was established in 2007 by the founder and president of MicroConstants, Inc., a GLP-compliant bioanalytical and pharmacokinetic-specialty Contract Research Organization (CRO) in San Diego, California, USA. Located in Beijing, MicroConstants China is dedicated to providing premier quality preclinical and clinical bioanalytical and pharmacokinetics services to pharmaceutical and biotech companies worldwide. Its bioanalytical laboratory has been GLP-compliant since April of 2009. MicroConstants China also offers quality system consulting and project management services for toxicology studies and Phase I clinical trials.

For more information, contact:

Jessica Hou
MicroConstants China Inc.
This e-mail address is being protected from spambots. You need JavaScript enabled to view it.
+86 (10) 5977-6728